Coenzyme Competitors
| PPII Stock | USD 0.0002 0.00 0.00% |
Coenzyme A vs Aspyra Correlation
No risk reduction
The correlation between Coenzyme A and APYI is 1.0 (i.e., No risk reduction) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Coenzyme A and APYI in the same portfolio, assuming nothing else is changed.
Coenzyme A Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Coenzyme A and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Coenzyme and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Coenzyme A does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Coenzyme Stock performing well and Coenzyme A Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Coenzyme A's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| BRSF | 3.01 | 1.07 | 0.00 | (0.22) | 0.00 | 0.00 | 150.00 | |||
| ENCW | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| CLVR | 885.57 | 445.95 | 0.00 | 4.79 | 0.00 | 50.00 | 21,999 | |||
| AOBI | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| NRTSF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| HLTHQ | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| MYMX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| HTGMQ | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| CRFTF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| APYI | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cross Equities Net Income Analysis
Compare Coenzyme A and related stocks such as Brain Scientific, Enchanted World, and Clever Leaves Holdings Net Income Over Time
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ENCW | 229 K | 5.6 K | 5.6 K | 5.6 K | 5.6 K | 5.6 K | 5.6 K | 5.6 K | 5.6 K | 5.6 K | 5.6 K | 5.6 K | 5.6 K | 5.6 K | 5.6 K | 5.1 K | 5.3 K |
| HLTHQ | (20.6 M) | (20.6 M) | (20.6 M) | (20.6 M) | (20.6 M) | (20.6 M) | (20.6 M) | (20.6 M) | (20.6 M) | (20.6 M) | (47.4 M) | 33.1 M | (194.1 M) | (373.5 M) | (373.5 M) | (336.1 M) | (319.3 M) |
Coenzyme A and related stocks such as Brain Scientific, Enchanted World, and Clever Leaves Holdings Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Coenzyme A financial statement analysis. It represents the amount of money remaining after all of Coenzyme A operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Coenzyme A Competitive Analysis
The better you understand Coenzyme A competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Coenzyme A's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Coenzyme A's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Coenzyme A Competition Performance Charts
Five steps to successful analysis of Coenzyme A Competition
Coenzyme A's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Coenzyme A in relation to its competition. Coenzyme A's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Coenzyme A in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Coenzyme A's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Coenzyme A, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Coenzyme A position
In addition to having Coenzyme A in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Broad Debt ETFs Thematic Idea Now
Broad Debt ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Debt ETFs theme has 302 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Debt ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Coenzyme A Correlation with its peers. For more detail on how to invest in Coenzyme Stock please use our How to Invest in Coenzyme A guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is there potential for Pharmaceuticals market expansion? Will Coenzyme introduce new products? Factors like these will boost the valuation of Coenzyme A. Anticipated expansion of Coenzyme directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Coenzyme A listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (35.31) | Revenue Per Share 2.652 | Quarterly Revenue Growth 0.268 |
Coenzyme A's market price often diverges from its book value, the accounting figure shown on Coenzyme's balance sheet. Smart investors calculate Coenzyme A's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Coenzyme A's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Coenzyme A's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Coenzyme A should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Coenzyme A's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.